title: [Effect of vascular endothelial growth factor and tumor necrosis factor receptor for treatment of avascular necrosis of the femoral head in rabbits].
abstract: OBJECTIVE
  To evaluate the therapeutic effect of vascular endothelial growth factor (VEGF) and tumor necrosis factor receptor (TNFR) on avascular necrosis of the femoral head in rabbits.
  
  
  METHODS
  Avascular necrosis of the femoral head was induced in 26 New Zealand white rabbits by injections of horse serum and prednisolone. The rabbits were then divided into VEGF/TNFR treatment group, VEGF treatment group, and untreated model group, with another 4 normal rabbits as the normal control group. In the two treatment groups, the therapeutic agents were injected percutaneously into the femoral head. Enzyme-linked immunosorbent assay was performed to determine the concentration of TNF-alpha in rabbit serum followed by pathological examination of the changes in the bone tissues, bone marrow hematopoietic tissue and the blood vessels in the femoral head.
  
  
  RESULTS
  Compared with the model group, the rabbits with both VEGF and TNFR treatment showed decreased serum concentration of TNF-alpha with obvious new vessel formation, decreased empty bone lacunae in the femoral head and hematopoietic tissue proliferation in the bone marrow cavity.
  
  
  CONCLUSIONS
  Percutaneous injection of VEGF and TNFR into the femoral head can significantly enhance bone tissue angiogenesis and ameliorate osteonecrosis in rabbits with experimental femoral head necrosis.
authors.affiliation: College of Biotechnology, Southern Medical University, Guangzhou 510515, China. hzhiming99@126.com
authors.forename: Zhi-ming
authors.initials: ZM
authors.lastname: Hu
authors.forename: Ming-qian
authors.initials: MQ
authors.lastname: Zhou
authors.forename: Ji-min
authors.initials: JM
authors.lastname: Gao
mesh_terms: D000818:Animals; D004359:Drug Therapy, Combination; D005260:Female; D005271:Femur Head Necrosis / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D011817:Rabbits; D011897:Random Allocation; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D042461:Vascular Endothelial Growth Factor A / Q000627:therapeutic use*
chemical_list: D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A